Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adoptive immunotherapy for cutaneous T-cell lymphomas.

P S Sastry1

  • 1Royal Marsden Hospital, Sutton, Surrey, UK.

Medical Hypotheses
|August 28, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Learning Gaussian-Bernoulli RBMs Using Difference of Convex Functions Optimization.

IEEE transactions on neural networks and learning systems·2021
Same author

On Robustness of Neural Architecture Search Under Label Noise.

Frontiers in big data·2021
Same author

Lipids of some thermophilic fungi.

Lipids·2016
Same author

Noise tolerance under risk minimization.

IEEE transactions on cybernetics·2012
Same author

Geometric decision tree.

IEEE transactions on systems, man, and cybernetics. Part B, Cybernetics : a publication of the IEEE Systems, Man, and Cybernetics Society·2011
Same author

Relaxation labeling with learning automata.

IEEE transactions on pattern analysis and machine intelligence·2011
Same journal

Calcitonin Gene-Related Peptide-Induced Central Sensitization: A Hypothesis for Long COVID Symptoms.

Medical hypotheses·2026
Same journal

Subclinical mastitis during lactation: a modifiable risk factor for breast cancer?

Medical hypotheses·2025
Same journal

The Role of Hemispheric Sensory Shifts: Impacts on Stretch Reflex and Motor Plasticity Post-Stroke.

Medical hypotheses·2025
Same journal

Neuron-Targeted Exosome Therapy: A Novel Approach for Treating Cardiogenic Dementia via RyR2 Inhibition.

Medical hypotheses·2025
Same journal

How the Somatosensory System Adapts to the Motor Change in Stroke: A Hemispheric Shift?

Medical hypotheses·2024
Same journal

Unstable Plaque is a Treatable Cause of Cognitive Decline.

Medical hypotheses·2024
See all related articles

Donor lymphocyte infusions may treat cutaneous T-cell lymphomas by leveraging a graft-versus-lymphoma effect. Clinical trials are proposed to investigate this adoptive immunotherapy approach for skin lymphomas.

Area of Science:

  • Oncology
  • Immunology
  • Dermatology

Background:

  • Cutaneous T-cell lymphomas (CTCL) primarily affect the skin.
  • Allogeneic bone-marrow transplantation can cause graft-versus-host disease, often involving the skin.
  • Adoptive immunotherapy using donor lymphocyte infusions is gaining traction for post-transplant relapse and prevention.

Purpose of the Study:

  • To propose the hypothesis that human leucocyte antigen (HLA)-matched donor lymphocyte infusions can induce a graft-versus-leukemia/lymphoma (GVL) effect in CTCL.
  • To suggest the initiation of clinical trials to evaluate this therapeutic strategy.

Main Methods:

  • The study is based on a hypothesis and literature review, not direct experimentation.
  • It considers the established use of donor lymphocyte infusions in other contexts.

Related Experiment Videos

  • It draws parallels between graft-versus-host disease and potential graft-versus-lymphoma effects.

    • Main Results:

    • No direct results are presented as the study is hypothesis-driven.
    • The potential for a GVL effect from HLA-matched donor lymphocytes is theorized.
    • The rationale for exploring this in CTCL is outlined.

    Conclusions:

    • Donor lymphocyte infusions represent a potential therapeutic avenue for CTCL.
    • Further clinical investigation is warranted to establish the efficacy and safety of this approach.
    • This strategy could offer a novel treatment option for patients with cutaneous T-cell lymphomas.